Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
about
QSAR studies on a number of pyrrolidin-2-one antiarrhythmic arylpiperazinyls.Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist.Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.Structure-Activity Relationship Studies of a Number of α1 -Adrenoceptor Antagonists and Antiarrhythmic Agents.
P2860
Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Design, synthesis and pharmaco ...... nd alpha-adrenolytic activity.
@en
Design, synthesis and pharmaco ...... nd alpha-adrenolytic activity.
@nl
type
label
Design, synthesis and pharmaco ...... nd alpha-adrenolytic activity.
@en
Design, synthesis and pharmaco ...... nd alpha-adrenolytic activity.
@nl
prefLabel
Design, synthesis and pharmaco ...... nd alpha-adrenolytic activity.
@en
Design, synthesis and pharmaco ...... nd alpha-adrenolytic activity.
@nl
P2093
P1476
Design, synthesis and pharmaco ...... and alpha-adrenolytic activity
@en
P2093
Alicja Nowaczyk
Barbara Malawska
Katarzyna Kulig
P304
P356
10.1016/J.EJMECH.2009.04.028
P577
2009-04-22T00:00:00Z